← Back to Search


Nasogastric Balloon Placement for Respiratory Function(VIREM Trial)

The Hospital for Sick Children (SickKids), Toronto, Canada
Targeting 3 different conditionsPlacement of nasogastric balloonN/ARecruitingResearch Sponsored by University Hospital, Antwerp

VIREM Trial Summary

This trial will study the effects of a patient's inspiratory effort on their lungs and diaphragm.

Eligible Conditions
  • Respiratory Function Tests
  • Respiratory Muscles
  • Artificial Respiration

VIREM Trial Eligibility Criteria

Inclusion Criteria

You will be eligible if you check “Yes” for the criteria below

VIREM Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from date of intubation until the date of death from any cause, whichever came first, assessed up to 4 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and from date of intubation until the date of death from any cause, whichever came first, assessed up to 4 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Tidal esophageal pressure swing (∆Pes) - D1
Tidal esophageal pressure swing (∆Pes) - D2
Tidal esophageal pressure swing (∆Pes) - D3
+5 more
Secondary outcome measures
Dead space ventilation (VD) - D1
Dead space ventilation (VD) - D2
Continuous Positive Airway Pressure
+87 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

VIREM Trial Design

1Treatment groups
Experimental Treatment
Group I: Overall groupExperimental Treatment1 Intervention
Placement of a nasogastric balloon

Find a Location

Who is running the clinical trial?

532 Previous Clinical Trials
200,339,076 Total Patients Enrolled
Universitaire Ziekenhuizen LeuvenOTHER
849 Previous Clinical Trials
1,244,123 Total Patients Enrolled
University Hospital, AntwerpLead Sponsor
279 Previous Clinical Trials
112,871 Total Patients Enrolled

Media Library

Placement of nasogastric balloon (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05459116 — N/A
Respiratory Function Tests Research Study Groups: Overall group
Respiratory Function Tests Clinical Trial 2023: Placement of nasogastric balloon Highlights & Side Effects. Trial Name: NCT05459116 — N/A
Placement of nasogastric balloon (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05459116 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any openings left to participate in this clinical research?

"Affirmative. According to clinicaltrials.gov, this medical trial which was initially advertised on September 21st 2022 is currently recruiting participants. Approximately 150 patients need to be enrolled from a single site."

Answered by AI

What is the participant quota for this research experiment?

"Affirmative. The information hosted on clinicaltrials.gov suggests that this research project, which was first posted on September 21st 2022, is in the process of participant recruitment. 150 people are required to join from a single site."

Answered by AI
~32 spots leftby Apr 2024